ArticleInflammation2022

TLR4-IN-C34 Inhibits Lipopolysaccharide-Stimulated Inflammatory Responses via Downregulating TLR4/MyD88/NF-κB/NLRP3 Signaling Pathway and Reducing ROS Generation in BV2 Cells.

Shan-Shan Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.